UPDATE 3-U.S. FDA panel backs Puma Biotech's breast cancer drug; stock soars

WASHINGTON, May 24 (Reuters) - Puma Biotechnology Inc's experimental breast cancer drug reduces the risk of the disease's recurrence and should be approved, a U.S. Food and Drug Administration advisory committee concluded on Wednesday, sending the stock up as much as 30 percent.

by reutersCOMPANYNEWS via Endless Supplies .Biz - News